Quarterly Financials Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Revenue 24
31
36
36
25
28
31
33
22
28
33
34
23
34
34
36
39
42
44
47
48
44
45
45
Expenses 20
26
30
30
21
24
25
28
17
22
26
26
18
27
28
30
32
35
39
42
42
40
39
38
EBITDA 4
5
6
6
4
4
6
5
5
6
7
7
5
7
6
7
7
7
5
6
6
4
6
7
Operating Profit % 18 %
16 %
16 %
15 %
13 %
15 %
18 %
16 %
20 %
22 %
19 %
19 %
22 %
17 %
17 %
17 %
17 %
17 %
11 %
11 %
12 %
8 %
12 %
15 %
Depreciation 1
1
1
1
1
1
1
1
0
1
1
2
2
2
2
2
2
2
2
2
2
2
3
2
Interest 0
0
0
0
0
0
0
0
0
0
0
1
1
1
1
1
1
1
1
1
2
1
1
1
Profit Before Tax 4
4
5
5
3
3
5
4
4
5
5
5
3
4
4
4
4
5
3
3
3
2
2
4
Tax 1
1
1
1
1
1
1
1
0
1
1
1
1
1
1
0
1
1
1
1
1
1
1
1
Net Profit 2
3
4
4
3
2
3
3
4
4
4
4
3
4
4
4
4
4
2
2
2
1
1
3
EPS in ₹ 2.06
2.75
3.18
3.05
2.05
1.84
2.64
2.47
2.99
3.40
3.46
3.09
2.25
2.94
2.85
2.98
3.03
3.12
1.17
1.60
1.61
0.63
0.71
2.30
Above figures are in Rs. Crores Balance Sheet 2019
2020
2021
2022
2023
2024
Total Assets 137
181
194
226
279
295
Fixed Assets 24
34
90
93
93
92
Current Assets 96
104
96
123
163
160
Capital Work in Progress 15
41
0
0
0
0
Investments 0
0
0
0
0
0
Other Assets 98
107
104
133
186
203
Total Liabilities 137
181
194
226
279
295
Current Liabilities 49
57
53
73
83
85
Non Current Liabilities 1
4
8
7
3
3
Total Equity 87
121
133
147
193
207
Reserve & Surplus 75
109
121
134
178
194
Share Capital 12
12
12
12
13
13
Above figures are in Rs. Crores Cash Flow 2019
2020
2021
2022
2023
2024
Net Cash Flow -14
-5
1
-0
17
-6
Investing Activities -15
-37
-18
-9
-6
-6
Operating Activities 4
13
13
4
-6
-7
Financing Activities -4
19
6
4
29
6
Above figures are in Rs. Crores % Holding Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Promoter 44.83 %
44.83 %
44.83 %
43.60 %
43.60 %
43.60 %
43.21 %
43.21 %
43.21 %
43.21 %
43.21 %
43.21 %
43.21 %
42.99 %
42.99 %
42.99 %
FIIs 0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.21 %
0.11 %
0.06 %
0.06 %
0.05 %
DIIs 0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.13 %
0.20 %
0.20 %
0.20 %
0.00 %
0.68 %
0.99 %
1.17 %
1.17 %
0.87 %
Government 0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.06 %
Public / Retail 33.04 %
32.97 %
33.17 %
34.23 %
34.30 %
35.02 %
30.94 %
31.35 %
31.49 %
31.43 %
31.80 %
31.90 %
31.95 %
31.57 %
32.43 %
32.96 %
Others 22.12 %
22.20 %
21.99 %
22.18 %
22.10 %
21.38 %
25.72 %
25.24 %
25.10 %
25.16 %
24.99 %
24.00 %
23.74 %
24.21 %
23.34 %
23.08 %
No of Share Holders 4,965
5,263
5,595
9,140
9,300
9,107
8,418
8,273
8,233
8,272
9,419
10,252
10,639
10,652
10,792
10,576
Dividend Per Share (₹) 0.00 0.00 0.00 0.00 0.00 1 1 1 1 0.00 Dividend Yield (%) 0.00 0.00 0.00 0.00 0.00 0.16 0.15 0.26 0.21 0.00
Login to View
This information is available only for users of ScanX and Dhan.To proceed ahead, Login Open Account
Announcment Under Regulation 30 (LODR)- Update 2 hours ago Closure of Trading Window 3 days ago Shareholder Meeting / Postal Ballot-Scrutinizer"s Report 5 days ago Announcement Under Regulation 30 (LODR)- Expansion Into Regulated Markets And Long Term Vision 6 days ago Shareholder Meeting / Postal Ballot-Outcome of EGM 7 days ago Announcement under Regulation 30 (LODR)-Trading Plan under SEBI (PIT) Regulations 2015 Mar 22, 2025 Corrigendum-Notice Of The Extra Ordinary General Meeting Scheduled To Be Held On Wednesday March 26 2025 At 12:00 Noon Through Video Conferencing ("VC")/ Other Audio-Visuals Means ("OAVM") Mar 20, 2025 Announcement Under Regulation 30 (LODR) - Updates Mar 07, 2025 Announcement under Regulation 30 (LODR)-Newspaper Publication Mar 04, 2025 Notice Of Extra Ordinary General Meeting - Wednesday March 26 2025 Mar 03, 2025 Announcement Under Regulation 30 (LODR) - MBL Has Been Awarded By Honble Health Minister Of Ethiopia Feb 27, 2025 Announcement Under Regulation 30 (LODR) - MBL Has Been Awarded By Honble Health Minister Of Ethiopia Feb 27, 2025 Announcement under Regulation 30 (LODR)-Issue of Securities Feb 26, 2025 Announcement under Regulation 30 (LODR)-Issue of Securities Feb 26, 2025 Announcement Under Regulation 30 Of (LODR)- Clarification On Price Movement Feb 25, 2025 Announcement Under Regulation 30 Of (LODR)- Clarification On Price Movement Feb 25, 2025 Clarification sought from Medicamen Biotech Ltd Feb 24, 2025 Board Meeting Intimation for Issunce Of One Or More Instruments Including Equity Shares/Convertible Securities Either By Way Of Preferential Issue/ Right Issue/QIP Or Any Other Mode. Feb 21, 2025 Announcement Under Regulation 30 (LODR)- Updates (Manufacturing And Supply Agreement) Feb 19, 2025 Announcement under Regulation 30 (LODR)-Newspaper Publication Feb 13, 2025 Announcement under Regulation 30 (LODR)-Change in Management Feb 11, 2025 Financial Results For The Quarter Ended On 31.12.2024 Feb 11, 2025 Integrated Filing (Financial) Feb 11, 2025 Board Meeting Intimation for Consideration And Approval Of The Standalone And Consolidated Unaudited Financial Results Of The Company For The Quarter Ended On December 31 2024 Feb 04, 2025 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 Jan 22, 2025 Closure of Trading Window Dec 31, 2024 Clarification On Price Movement Dec 06, 2024 Clarification sought from Medicamen Biotech Ltd Dec 06, 2024 Announcement under Regulation 30 (LODR)-Newspaper Publication Dec 06, 2024 Announcement under Regulation 30 (LODR)-Newspaper Publication Nov 15, 2024 Investor Presentation - Q2- 2024 Nov 14, 2024 Outcome Of The Board Meeting Held On 14-11.2024 Nov 14, 2024 Board Meeting Intimation for Considering Un-Audited Standalone And Consolidated Financial Results Of The Company For The Quarter And Half Year Ended On September 30,2024 Nov 07, 2024 US FDA Approved The Sterile Injectable Oncology Formulation Facility At Haridwar And Establishment Inspection Report (EIR) Released Oct 25, 2024 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 Oct 09, 2024 Closure of Trading Window Oct 04, 2024 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation Sep 27, 2024 Shareholder Meeting / Postal Ballot-Scrutinizer''s Report Sep 27, 2024 Shareholder Meeting / Postal Ballot-Outcome of AGM Sep 26, 2024 Announcement under Regulation 30 (LODR)-Trading Plan under SEBI (PIT) Regulations, 2015 Sep 18, 2024 EU GMP Certification Received For BHIWADI Formulation Facility Of Medicamen Biotech Limited. Sep 11, 2024 Announcement under Regulation 30 (LODR)-Newspaper Publication Sep 03, 2024 Corporate Action- Book Closure Intimation Sep 02, 2024 Reg. 34 (1) Annual Report. Sep 02, 2024 31St Annual General Meeting Sep 02, 2024 Announcement under Regulation 30 (LODR)-Newspaper Publication Aug 14, 2024 Business Responsibility and Sustainability Reporting (BRSR) Aug 13, 2024 Board Meeting Outcome for Outcome Of Board Meeting Aug 13, 2024 Financial Results For The Quarter Ended On 30.06.2024 Aug 13, 2024 Board Meeting Intimation for The Approval Un-Audited Financial Results (Standalone & Consolidated) For The Quarter Ended On June 30, 2024 And For Approval Of Draft Financial Results For The FY 2023-24 Aug 07, 2024 RSI(14)
Neutral
53.51
ATR(14)
Less Volatile
31.48
STOCH(9,6)
Neutral
65.71
STOCH RSI(14)
Overbought
93.49
MACD(12,26)
Bullish
5.25
ADX(14)
Weak Trend
12.79
UO(9)
Bearish
46.30
ROC(12)
Uptrend And Accelerating
12.40
WillR(14)
Overbought
-16.14